A Dark Vector Cognition product

Item 5. OTHER INFORMATION

4K characters. Original on sec.gov · Markdown

Item 5. OTHER INFORMATION

DIRECTOR AND EXECUTIVE OFFICER TRADING PLANS AND ARRANGEMENTS

Our directors and executive officers may enter into trading plans or other arrangements with financial institutions to purchase or sell shares of our common stock. These plans or arrangements may constitute Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements, in each case as defined under Item 408(a) of Regulation S-K.

Set forth below is a summary of the adoption, modification, and termination activity of our directors and executive officers with respect to Rule 10b5-1 trading plans during the three months ended December 31, 2024:

Name & TitleAdoption DateTermination DateContract End DateAggregate Shares Covered (in ones) (3)
Steven Fasching, Chief Financial OfficerJune 4, 2024November 8, 2024 (1)January 31, 202518,000 (2)
Bonita Stewart, DirectorJune 4, 2024November 22, 2024 (1)May 29, 202513,500 (2)
Steven Fasching, Chief Financial OfficerNovember 22, 2024*June 3, 202512,702
Angela Ogbechie, Chief Supply Chain OfficerNovember 6, 2023October 31, 2024 (1)November 1, 20245,418 (2)

(1) This trading plan was terminated automatically prior to the contract end date upon the sale of all shares covered by the plan.

(2) Aggregated shares covered have been adjusted to reflect the stock split. Refer to Note 1, “General,” of our condensed consolidated financial statements in Part I, Item 1 within this Quarterly Report for further information.

(3) The actual number of shares sold under the plan will depend on the vesting of certain performance-based equity awards and the number of shares withheld by us to satisfy our income tax withholding obligations and may vary from the number provided herein.

*Not applicable.

During the three months ended December 31, 2024, no non-Rule 10b5-1 trading arrangements were adopted, modified, or terminated by our directors or executive officers.

Previous: Item 1A. RISK FACTORS · Next: Item 6. EXHIBITS